Sermorelin & Ipamorelin Blend
Summary
Sermorelin (GHRH analog) and Ipamorelin (selective ghrelin receptor agonist) are growth hormone secretagogues that work through complementary pathways to stimulate endogenous GH release. While both peptides have been studied individually in clinical trials, no published peer-reviewed studies have specifically examined their combination in humans. The theoretical synergy is based on established GHRH-GHRP interactions, where GHRH analogs and ghrelin mimetics act synergistically to produce enhanced GH secretion beyond either compound alone. Clinical evidence shows sermorelin increases 24-hour GH levels and lean body mass, while ipamorelin demonstrates selective GH stimulation without affecting cortisol or ACTH, though its clinical efficacy remains limited based on failed Phase II trials.
Potential Benefits
Key Benefits
This is a combination product containing multiple peptides. See individual component peptides for detailed benefits.
Safety Information
Safety Considerations
This is a combination product. Please review the safety information for each individual component peptide before use.